Cite Filings / AVTX / 0001628280-19-014775

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

Avalo Therapeutics, Inc. Filed 2019-12-05 Acc 0001628280-19-014775

Documents 1

425 Prospectus/Communication re Business Combination , a8-ksigningofaevimergeragr.htm

Around this filing

2019-12-11 425 Prospectus/Communication re Business Combination
2019-12-11 4 Changes in Ownership
2019-12-11 4 Changes in Ownership
2019-12-09 8-K Other events
2019-12-06 SC 13D/A Beneficial Ownership Report
2019-12-05 425 Prospectus/Communication re Business Combination
2019-12-05 8-K Material agreement · Unregistered share sale · Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading a8-ksigningofaevimergeragr.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…